Jimmy Carter seems to have gotten the perfect drug to treat his cancer. But scientists need to understand a lot more about tumors before personalized cancer treatments are available for everyone.
Some companies have bought the patents for old drugs, then abruptly upped the prices — from $13 per pill to $750 in one case. Irate senators call it price gouging.
Drug prices are a hot topic in politics. One company raised the price of a $1.50 drug to $750. Drugs to cure hepatitis C routinely cost more than $10,000 — and more for a full course of treatment.
A state analysis reveals that the majority of overdose deaths in 2014 came from heroin or prescription opioids taken in combination with cocaine, anti-anxiety medications or alcohol.
The wave of mass shootings in the U.S. is renewing a debate over treating gun violence as a public health issue. Congress has stood in the way of federal funding for studying injuries and deaths.
The first studies of cannabidiol show promise for treatment-resistant epilepsy, but researchers caution that these are preliminary results and bigger, better studies are needed.
Young doctors being trained at dozens of hospitals around the country are being asked to work up to 30 hours straight as part of a study. Critics say the study is risky and unethical.
If children in the Gaza Strip need to get treatment for cancer, they face a bureaucratic morass — and a trek outside Gaza. One nonprofit hopes to fix that by building a pediatric cancer center there.
The unusual meeting was called to consider a ban on certain uses of a new technique that can make precise changes in DNA. The main concern is altering genes in human sperm, eggs and embryos.